| Breakdown | TTM | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.30M | 14.10M | 12.00M | 10.30M | 8.40M | 13.20M |
| Gross Profit | 9.50M | 8.30M | 8.00M | 5.00M | 2.70M | 4.70M |
| EBITDA | -1.60M | -2.90M | -3.60M | -7.00M | -5.60M | -3.40M |
| Net Income | -3.10M | -3.60M | -4.50M | -12.30M | -6.80M | -4.90M |
Balance Sheet | ||||||
| Total Assets | 17.80M | 19.90M | 23.10M | 27.40M | 37.30M | 24.30M |
| Cash, Cash Equivalents and Short-Term Investments | 2.70M | 5.10M | 9.00M | 15.60M | 24.20M | 11.50M |
| Total Debt | 400.00K | 600.00K | 500.00K | 600.00K | 700.00K | 500.00K |
| Total Liabilities | 8.70M | 8.80M | 8.50M | 8.50M | 6.30M | 6.70M |
| Stockholders Equity | 9.10M | 11.10M | 14.60M | 18.90M | 31.00M | 17.60M |
Cash Flow | ||||||
| Free Cash Flow | -1.80M | -1.30M | -6.80M | -6.70M | -5.70M | -3.20M |
| Operating Cash Flow | -1.80M | -1.10M | -4.70M | -6.30M | -4.90M | -2.90M |
| Investing Cash Flow | -2.20M | -2.60M | -1.60M | -2.00M | -2.30M | 82.70M |
| Financing Cash Flow | -300.00K | -200.00K | -300.00K | -300.00K | 19.90M | 100.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | £95.54M | 152.71 | 4.75% | ― | 0.97% | -71.58% | |
68 Neutral | £163.66M | 37.63 | 5.22% | 0.80% | 22.80% | -32.13% | |
68 Neutral | £125.75M | -33.80 | -0.19% | ― | 31.86% | -115.22% | |
63 Neutral | £68.99M | 23.49 | -1.09% | 2.00% | 9.69% | -319.35% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | £32.70M | -28.61 | -7.07% | ― | 1.73% | -68.87% | |
57 Neutral | £15.39M | -1.93 | -29.25% | ― | 10.00% | 34.02% |